Skip to main content
. 2022 Sep 22:10.1111/cbdd.14136. Online ahead of print. doi: 10.1111/cbdd.14136

FIGURE 3.

FIGURE 3

Illustration of ligand‐ and structure‐based drug design on SARS‐CoV‐2 PLpro (redesigned by the authors of present work with permission from Amin et al. (2021))